Modifiable factors associated with Huntington's disease progression in presymptomatic participants

Andres Gil‐Salcedo, Renaud Massart, Laurent Cleret de Langavant, Anne‐Catherine Bachoud‐Levi

Open source

DOI
10.1002/acn3.52120
Published
2024-06-10
Container
Annals of Clinical and Translational Neurology
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/acn3.52120,
  title = {Modifiable factors associated with Huntington's disease progression in presymptomatic participants},
  author = {Andres Gil‐Salcedo and Renaud Massart and Laurent Cleret de Langavant and Anne‐Catherine Bachoud‐Levi},
  year = {2024},
  journal = {Annals of Clinical and Translational Neurology},
  doi = {10.1002/acn3.52120},
  url = {https://doi.org/10.1002/acn3.52120}
}

RIS

TY  - JOUR
TI  - Modifiable factors associated with Huntington's disease progression in presymptomatic participants
AU  - Andres Gil‐Salcedo
AU  - Renaud Massart
AU  - Laurent Cleret de Langavant
AU  - Anne‐Catherine Bachoud‐Levi
PY  - 2024
JO  - Annals of Clinical and Translational Neurology
DO  - 10.1002/acn3.52120
UR  - https://doi.org/10.1002/acn3.52120
ER  - 

APA

Gil‐Salcedo, A., Massart, R., Langavant, L. C. D., & Bachoud‐Levi, A. (2024). Modifiable factors associated with Huntington's disease progression in presymptomatic participants. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.52120

Source records